Navigation Links
China pharmaceutical manufacturing industry, 2013
Date:2/20/2013

NEW YORK, Feb. 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China pharmaceutical manufacturing industry, 2013

http://www.reportlinker.com/p0179487/China-pharmaceutical-manufacturing-industry-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing

China pharmaceutical manufacturing industry, 2013 is valuable for anyone who wants to invest in the pharmaceutical manufacturing industry, to get Chinese investments; to import into China or export from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy as China is leading the way; or to compete in the segment. The report provides the whole set of the industry data, in-depth analysis and detailed insight into the pharmaceutical manufacturing industry, market drivers, key enterprises and their strategies, as well as technologies and investment status, risks and trends.

Data sources: Governmental statistics organizations, market research (monitoring) centers, industry associations and institutions, import and export statistics organizations, and others.

This report is divided into 9 parts 19 chapters as follow:

Part 1 Industry Overview

1 Industry definition and development overview

2 Industry macroscopic environment and its influence analysis

3 Industry international market analysis

4 Industry domestic market analysis

Part 2 Basic indices

5 Analysis of the industry's scale and condition: 2008-2012

6 Status analysis of gross assets analysis: 2008-2012

Part 3 Economic operation

7 Analysis of gross industrial output: 2008-2012

8 Industry sales income analysis: 2008-2012

9 Industry gross profit analysis

10 Industry import/export analysis in 2012

Part 4 Competition landscape

11 Industry competition landscape analysis

12 Industry key enterprises' competitive power comparison (top 20)

Part 5 Key enterprises

13 Comparative analysis of the economic indicators of the industry's key enterprises

Part 6 Business strategy

14. Development bottlenecks and coping strategies in Industry

15 Enterprise development strategy analysis and recommendations in Industry

Part 7 Market investment

16 Comparison and analysis of investment activity coefficient and rate of return on investment in Industry

17 Industry investment environment and risks analysis

Part 8 Technology

18 Status and trends of the newest technology applications in Industry

Part 9 Developments and trends

19 Development trends and operation capacity forecast for 2013-2017

There are more than 150 figures and tables in the report.

Report format: PDF

Knowledge is power. If you want to invest in, import into/from, partner with, or compete against any of the companies in this field, then China pharmaceutical manufacturing industry, 2013 is required reading.

This report will take 5 business days to deliver.

Part 1 Industry Overview

1 Industry definition and development overview

1.1 Definition of the industry and its core products

1.2 Industry main characteristics and development history



2 Industry macroscopic environment and its influence analysis

2.1 Current macroeconomic developments and trends

2.2 Industry newest policy and related laws and rules

2.3 Upstream, downstream industry development status



3 Industry international market analysis

3.1 International market development status

3.2 Key countries and regions development levels

3.3 International market movement and development trend analysis



4 Industry domestic market analysis

4.1 Domestic market development status

4.2 Trends in the domestic market

4.3 Sub-industry development status (or main industry development status)



Part 2 Basic indices

5 Analysis of the industry's scale and condition: 2008-2012

5.1 Number of enterprises in the industry: 2008-2012

5.2 Number of loss-making enterprises in the industry: 2008-2012

5.3 Total loss of the industry: 2008-2012

5.4 Number of personnel employed by the industry: 2008-2012



6 Status analysis of gross assets analysis: 2008-2012

6.1 Status and analysis of gross assets: 2008-2012

6.2 Status and analysis of fixed assets: 2008-2012

6.3 Gross floating asset analysis: 2008-2012



Part 3 Economic operation

7 Analysis of gross industrial output: 2008-2012

7.1 Industry gross output value: 2008-2012

7.2 Distribution of gross industrial output value by geographic area: 2012

7.3 Comparison of the top 20 enterprises (based on highest gross output value)



8 Industry sales income analysis: 2008-2012

8.1 Sales income analysis in 2008-2012

8.2 Regional distribution status of sales income in 2012

8.3 Comparison of the top 20 enterprises (based on highest gross sales revenue) in 2012



9 Industry gross profit analysis

9.1 Gross profit analysis: 2008-2012

9.2 Regional distribution status of gross profit in 2012

9.3 Comparison of the top 20 enterprises (based on highest gross profit) in 2012



10 Industry import/export analysis in 2012

10.1 Import/export monthly status in 2012

10.2 Distribution of import/export Customs and countries in 2012

10.3 Distribution of import/export product categories in 2012



Part 4 Competition landscape

11 Industry competition landscape analysis

11.1 Regional market competition landscape

11.2 Comparison of enterprise's market share (top 20)



12 Industry key enterprises' competitive power comparison (top 20)

12.1 Comparison analysis of key enterprises' total assets

12.2 Comparison analysis of key enterprises' employees

12.3 Comparison analysis of key enterprises' yearly revenue

12.4 Comparison analysis of key enterprises' export turnover value

12.5 Comparison analysis of key enterprises' total profit

12.6 Comparison analysis and recommendations on key enterprises' overall competitive power



Part 5 Key enterprises

13 Comparative analysis of the economic indicators of the industry's key enterprises

13.1 Geographical distribution

13.2 Competition status analysis of company 1

A Enterprise' basic information

B Enterprise' balance sheet analysis

C Enterprise' business operation analysis

D Enterprise' operating expense and cost analysis

E Enterprise' industrial intermediate inputs and cash flow analysis

F Enterprise' non-operating expenses analysis



......



13.21 Competition status analysis of company 20

A Enterprise' basic information

B Enterprise' balance sheet analysis

C Enterprise' business operation analysis

D Enterprise' operating expense and cost analysis

E Enterprise' industrial intermediate inputs and cash flow analysis

F Enterprise' non-operating expenses analysis



Part 6 Business strategy

14. Development bottlenecks and coping strategies in Industry

14.1 Development bottlenecks

14.2 Coping strategies



15 Enterprise development strategy analysis and recommendations in Industry

15.1 Enterprise business strategy analysis and recommendations

15.2 Marketing strategy, analysis, and recommendations



Part 7 Market investment

16 Comparison and analysis of investment activity coefficient and rate of return on investment in Industry

16.1 Industry activity coefficient comparison and analysis

16.2 Comparison and analysis on industry rate of return on investment



17 Industry investment environment and risks analysis

17.1 Investment environment analysis

17.2 Investment risks analysis

17.3 Investment recommendations



Part 8 Technology

18 Status and trends of the newest technology applications in Industry

18.1 Status of the newest technology applications

18.2 Trends of the newest technology applications



Part 9 Developments and trends

19 Development trends and operation capacity forecast for 2013-2017

19.1 Development trends

19.2 Operation capacity forecast for 2013-2017

To order this report:
Manufacturing Industry: China pharmaceutical manufacturing industry, 2013

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. CentraState and Freehold Radiology Group train physicians from China
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report
5. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
6. China Biologic Products Reports Higher Results for the First Quarter 2012
7. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
8. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
9. China Botanic Attends 67th PHARMCHINA Fair
10. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
11. China Botanic Attends the 111th China Import and Export Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):